Showing results (1071-1080 of 1,255) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|November 28, 2020
The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancerAmit Singnurkar, Anand Swaminath, Ur Metser, et al.Cancer Treatment and Research Communications|November 28, 2020
Efficacy and tolerability of metronomic chemotherapy in patients with metastatic breast cancer - an international experience in West Sweden and in the South of IrelandCatherine Weadick, Karolina Larsson, Seamus O'Reilly, et al.Cancer Treatment and Research Communications|June 13, 2021
Clinical and oncological outcomes of surgery in Anorectal melanoma in Asian population: A 15 year analysis at a tertiary cancer instituteViswanth Kottakota, Vikas Warikoo, Ajay Kumar Yadav, et al.Cancer Treatment and Research Communications|May 24, 2022
The analysis of breast cancer survival in East Azerbaijan province of Iran; prognostic impact of chemotherapy and hormone therapy protocolsZohreh Sanaat, Jalil Vaez Gharamaleki, Yosra Vaez Gharamaleki, et al.Cancer Treatment and Research Communications|May 25, 2022
Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatinRachel Coyle, Maureen J O'Sullivan, Daniela M ZistererCancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.Cancer Treatment and Research Communications|January 31, 2021
Osteosarcoma, personalized medicine, and tissue engineering; an overview of overlapping fields of researchAzam Bozorgi, Leila SabouriCancer Treatment and Research Communications|January 16, 2021
Non-rodent animal models of osteosarcoma: A reviewSommer Jarvis, Evgenia Koumadoraki, Nikolaos Madouros, et al.Cancer Treatment and Research Communications|February 16, 2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directionsAlessandro Rizzo, Giovanni BrandiCancer Treatment and Research Communications|February 21, 2021
Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinomaRobin Park, Mohammed Al-Jumayli, Kirk Miller, et al.Pageof 126